Colonoscopy is the gold standard for detecting colon cancer, but every year about 50 million people in the U.S. who qualify for a colonoscopy don't get it done, according to the American Cancer ...

It’s good news in the fight against colorectal cancer: A new test can detect the disease with a simple blood draw. But don’t cancel your colonoscopy just yet — that old standby is still more reliable ...

Colorectal cancer is the second-leading cause of cancer-related death in the U.S., even though it is highly treatable if caught early.2 The American Cancer Society estimates that more than 150,000 ...

FDA reviewers questioned the potential benefits of Guardant Health's blood-based test for colorectal cancer (CRC) screening in documents released ahead of an advisory committee meeting on Thursday.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced new real-world data published in Current Medical Research and Opinion finding that the Shield blood-based ...

Approval demonstrates unique value of Shield test for CRC screening and improves Medicare pricing PALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (GH), a leading precision oncology company, ...

FDA panel voted favorably that there is reasonable assurance Shield is safe, effective, and outweigh its risks. The FDA is expected to decide whether to approve Shield later this year. Get ahead of ...

For the first time, the U.S. Food and Drug Administration has approved a blood test as a primary screening option for colorectal cancer. Guardant Health's Shield blood test was approved Monday as a ...

The space agency aims to send four astronauts around the moon early next year—and bring them safely home through intense heat ...